In vivo efficacy and safety of artemetherlumefantrine and amodiaquine–artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018
Malar. j. (Online); 20 (390), 2021
Background: Artemisinin-based combination therapy (ACT) has been the recommended first-line treatment for uncomplicated malaria in Mozambique since 2006, with artemether–lumefantrine (AL) and amodiaquine–artesunate (AS–AQ) as the first choice. To assess efficacy of currently used ACT, an in vivo...
Mozambique/epidemiology, Artemether/administration & dosage, Artesunate/administration & dosage, Algorithms, Malaria, Falciparum, Malaria/drug therapy, Lumefantrine, Infections, Efficacy/methods, 34628, Patients, Parasites, Lost to Follow-Up, Polymerase Chain Reaction, Recurrence, Safety, Therapeutics, Molecular Diagnostic Techniques